Triple-negative breast cancer: molecular characterization and targeted therapies

Author： Nicholson Allen   Bishop Jennifer   Lannin Donald   Killelea Brigid   Guo Xiaojia   Cha Charles   Dixon J Michael  

Publisher： Future Medicine

ISSN： 1758-1923

Source： Breast Cancer Management, Vol.2, Iss.5, 2013-09, pp. : 417-430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Development of targeted therapies for triple-negative breast cancer: can we harness tumor heterogeneity to improve patient outcomes?

By Diamond Jennifer R   Elias Anthony D  

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 175-178

Future Medicine

Access to resources Recommend Favorite

Molecular characteristics of recurrent triple-negative breast cancer

By                

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7326-7334

Spandidos Publications

Access to resources Recommend Favorite

Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer

By                      

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 163-171

Spandidos Publications

Access to resources Recommend Favorite

Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer

By Kim Sewha  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1681-1694

Springer Publishing Company

Access to resources Recommend Favorite

Imaging findings of triple-negative breast cancer

By Kawashima Hiroko  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 145-145

Springer Publishing Company

Access to resources Recommend Favorite